-
Amine hypothesis of Depression and Mania
- Mood disorders are related to alterations in levels of SER and NE
- *Low levels = depression
- *High levels = mania
-
Therapeutic overview: Depression
- TCA: most effective for pt severely dep
- SSRIs: drug of choice for mod dep pts
- Atypical antidep
- MAOI: historically 1st to be used now limited due to side effects
-
Therapeutic overview: Bipolar disorder
- Lithium salts (carbonate and citrate)
- Antidep(fluoxetine w/olanzapine)
- Antipsychotics (risperidone, olanzapine, quetiapine)
- Anticonvulsants (valproic acid, carbamazepine, lamotrigine)
-
TCA: pharmacokinetics
- orally active
- readily absorbed, sm int
- therapeutic effect req >2wks
- highly lipid soluble- penetrates CNS
- long 1/2 life - 5-40 hrs
- high plasma protein binding
- met by liver
- elimated by kidneys
-
TCA: side effects
- LOTS
- Major = CV: cardiac over + (tachycardia), slowing of A-V conductance
-
SSRI
- Most widely used, fewer side effects
- *- of uptake achieved rapidly (w/in hrs); however mood improvement occurs after more than 2 wks b/c + neurogenesis
-
SSRIs: Pharmacokinetics
- orally active
- readily absorbed, sm int
- high 1st pass hepatic met
- therapeutic effect req >2wks
- Long 1/2 life (1-3 day)
- high binding plasma proteins
- Block several liver enzymes = drug interactions
- eliminated by kidney
-
SSRI: Side effects
- Early: nausea, anxiety, sleep disturbance/insomnia
- Late: anorexia, sexual dysfunction, induction of mania in pts w/bipolar
-
SSRI: Drug interaction
Block several liver P450 enzymes: TCA, neuroleptics (haloperidol), antiarrhythmics, some beta-adrenorec antag
-
Atypical Drugs
- Bupropion: - DA reuptake (bipolar)
- Venlafaxine: - Ser and NE reuptake
- Nefazodone: - Ser reuptake and 5-HT2 rec
- Mirtazapine: inc NE and Ser release by blocking alpha-2 rec
-
Atypical: side effects
- headache, nausea, tinnitus, insomnia, nervousness
- fewer than TCA, often combo w/TCA, similar TI as TCAs and SSRIs
-
MAOIs = 3rd line
limited due to severe and often unpredictable side effects
-
MAOI: pharmacokinetics
- oral
- transdermal patch: selegiline
- therapeutic effect req 2-4 wks
- eliminated via kidney
- blocks MAO IRREV: activity persists long after drug met and eliminated
-
MAOI: Side effects
- Lots, severe, unpredictable
- *elevated tyramine (met by MAOI) will cause release of lg amts of catecholamines ->HTN, cardia arrhythmias, stroke, headache, nausea
-
Lithium Salts
- Drug of choice bipolar
- onset several wks (3-4(
- will substitute for Na and produce undesirable effects
- very toxic - extremely low TI
-
Lithium: pharmacokinetics
- oral
- rapid absorption from GI
- soluble ion
- peak plasma 2-4 hrs, 1/2 life 20-24 hrs
- eliminated by kidney
- reduced kidney function w/toxicity
-
Lithium: side effects
- CNS: tremors, mental confusion, convulsions, coma
- CV: arrythmias
-
Stimulants
- Amphetamine and its derivatives: amphetamine, dextroamphetamine, methylphenidate
- Tx: ADHD and Narcolepsy
- MOA: act by inc release of DA and NE in brain
- Numerouse side effects
- Other drugs: atomoxetine (ADHD, not +), Modafinil (narcolepsy)
-
Lithium Summary
- DRUG OF CHOICE FOR MAINTENANCE TX OF BIPOLAR
- alone or in combo w/antidep, neuroleptics and antiepileptics
- EXTREMELY low TI
-
MAOI Summary
- THIRD LINE DRUG for dep in pt resistant to other antidep
- inc presynaptic [MA] by blocking MAO
- Phenelzine, tranycypromine, selegiline, transdermal
- when combo w/SSRIs may lead to SER syndrome
- Restrictions in diet: tyramine-free food (cheese-effect)
-
Atypical Antidep: summary
- Heterogenous group of drugs to tx dep
- inc NE and 5HT synaptic transmission in brain
- Therapeutic efficacy similar to TCA and SSRIs
- Less toxic overall compared to TCA
- Bupropion, mirtazapine, venlafaxin, nefazodone
-
SSRIs: Summary
- FIRST LINE DRUG FOR TX DEP
- fewer side effects than TCA
- Fluoxetine, citalopram, escitalopram, sertaline
-
TCA: Summary
- Bloock reuptake of SER and NE
- Also block muscarinic, adrenergic, and HIS rec
- Amitriptyline, imipramine, nortriptyline, amoxapine
- Numerous side effects
-
Amphetamine: Side effects
- CNS: Euphoria, anxiety, vertigo, insomnia, confusion
- *Paranoia, psychoses, suicidal/homicidal impulses
- CV: Arrhythmias, HTN
- GI: Nausea, Diarrhea
- **POTENTIAL FOR ADDICTION
|
|